A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
OncoResponse, Inc.
OncoResponse, Inc.
Maria Sklodowska-Curie National Research Institute of Oncology
Maria Sklodowska-Curie National Research Institute of Oncology
N.N. Petrov National Medical Research Center of Oncology
AC Camargo Cancer Center
Hadassah Medical Organization
Broto, Javier MartÃn, M.D.
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
National Cancer Institute (NCI)